CORT News

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT

CORT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important April 21 Deadline in Securities Class Action - CORT

CORT 1-WEEK DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure

Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm

CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm

Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Corcept Therapeutics Incorporated (CORT), Lakeland Industries, Inc. (LAKE), and Navan, Inc. (NAVN) Announced by Holzer & Holzer, LLC

CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Corcept Therapeutics Incorporated to Contact the Firm Today!